News Headlines Article

San Diego Neurologist: New Alzheimer’s Drug Could Slow Or Halt Disease Progression

There is no effective treatment for Alzheimer’s disease yet, but researchers at UC San Diego said there is reason to be optimistic. They are testing a new drug for its potential to slow or halt the progression of the debilitating brain disease.

“We’re very excited about this trial,” said Howard Feldman, M.D., director of the Alzheimer’s Disease Cooperative Study, a program that develops and conducts nationwide clinical trials to test new Alzheimer’s drugs.

The latest study being launched, called T2 Protect AD, will examine the drug troriluzole on 350 people who have mild to moderate Alzheimer’s.